Radcliffe Capital Management, L.P. - EUCRATES BIOMEDICAL ACQU COR ownership

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q3 2022$1,032,000
+1.3%
102,9740.0%0.02%
+8.7%
Q2 2022$1,019,000
+0.4%
102,9740.0%0.02%0.0%
Q1 2022$1,015,000
+4.0%
102,974
+3.0%
0.02%
-11.5%
Q4 2021$976,000
-0.2%
100,0000.0%0.03%
-7.1%
Q3 2021$978,000
-0.7%
100,0000.0%0.03%
-9.7%
Q2 2021$985,000
-1.3%
100,0000.0%0.03%
-22.5%
Q1 2021$998,000
-0.7%
100,0000.0%0.04%
-36.5%
Q4 2020$1,005,000100,0000.06%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q3 2023
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$4,008,0001.47%
683 Capital Management, LLC 600,000$6,012,0000.46%
CVI Holdings, LLC 367,552$3,687,0000.29%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$2,004,0000.26%
SkyView Investment Advisors, LLC 71,773$719,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 999,999$10,020,0000.20%
GLAZER CAPITAL, LLC 1,022,411$10,245,0000.19%
METEORA CAPITAL, LLC 56,076$562,0000.14%
Cowen Investment Management LLC 50,000$501,0000.11%
First Trust Capital Management L.P. 208,598$2,090,0000.10%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders